금융 뉴스 허브

Biogen Stock Is Upgraded to Buy Ahead of Key Alzheimer’s Drug Study Details

Biogen stock receives a bullish upgrade based on expectations the market will cheer the company’s detailed data on its experimental Alzheimer’s drug.

POMDOCTOR regains compliance with Nasdaq minimum bid

RBC makes major S&P 500 sector shake-up, favors Tech over Utilities

Investing.com -- RBC Capital Markets made a series of S&P 500 sector rating changes, upgrading Technology to overweight and Consumer Discretionary to market weight while downgrading Communication Serv ...

Retail sales rise in June as earlier Amazon Prime Day provides a lift

Here Are Monday’s Best Wall Street Analyst Research Calls: Atmos Energy, Best Buy, Biogen, Capital One, Costco, Disney, Papa John’s International, Shopify, and More

Pre-Market Stock Futures: Futures are trading lower as we get ready for the start of second-quarter earnings this week, after a solid winning week on Wall Street. Renewed strikes against Iran and a ch ...

Tonix rises on Medicare payer deal for fibromyalgia drug

ASML is kicking off tech earnings. Here’s what to expect from Europe’s biggest semiconductor supplier.

The Dutch semiconductor-equipment manufacturer is reporting its second-quarter results on Wednesday, with analysts expecting a 15% rise in earnings per share year-over-year.

Wrap opens Q3 with $1.2M orders, reaffirms 100% growth target

At a glance: stocks gapping up premarket

Agenus rises premarket; Micron, Western Digital slide

Investing.com - U.S. stock futures were mixed on Monday as investors monitored a sharp selloff across the global memory-chip sector and assessed developments in the biotechnology space.

Compass Diversified restructures external manager fees to boost shareholder alignment; reaffirms outlook

Agenus stock gains after private placement of up to $340M